NGF and early-onset autosomal dominant Alzheimer disease: Exogenous nerve growth factor (NGF) improves the cholinergic neuron system and has therapeutic potential for neurodegenerative disorders such as Parkinson’s disease, Alzheimer’s disease, and diabetic polyneuropathy.